These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1506324)

  • 1. Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis.
    Hedberg M; Edlund C; Lindqvist L; Rylander M; Nord CE
    J Antimicrob Chemother; 1992 Feb; 29(2):105-13. PubMed ID: 1506324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a new beta-lactamase from Bacteroides uniformis.
    Hedberg M; Lindqvist L; Bergman T; Nord CE
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1458-61. PubMed ID: 7492085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
    Eley A; Greenwood D
    J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical properties and purification of metallo-beta-lactamase from Bacteroides fragilis.
    Bandoh K; Muto Y; Watanabe K; Katoh N; Ueno K
    Antimicrob Agents Chemother; 1991 Feb; 35(2):371-2. PubMed ID: 1902649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of a new beta-lactamase from Clostridium butyricum.
    Kesado T; Lindqvist L; Hedberg M; Tunér K; Nord CE
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1302-7. PubMed ID: 2802556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of novel beta-lactamase produced by Bacteroides fragilis.
    Yotsuji A; Minami S; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1983 Dec; 24(6):925-9. PubMed ID: 6607033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.
    Cuchural GJ; Malamy MH; Tally FP
    Antimicrob Agents Chemother; 1986 Nov; 30(5):645-8. PubMed ID: 3492173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of zinc ions on the activity of metallo-beta-lactamases of Bacteroides fragilis.
    Edwards R; Hashmi PS; Greenwood D
    J Med Microbiol; 1997 Sep; 46(9):807-9. PubMed ID: 9291894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum.
    Tunér K; Lindqvist L; Nord CE
    Antimicrob Agents Chemother; 1985 Jun; 27(6):943-7. PubMed ID: 3875311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis.
    Edwards R; Greenwood D
    J Antimicrob Chemother; 1996 Dec; 38(6):941-51. PubMed ID: 9023641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.
    Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K
    Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii.
    Hornstein M; Sautjeau-Rostoker C; Péduzzi J; Vessières A; Hong LT; Barthélémy M; Scavizzi M; Labia R
    FEMS Microbiol Lett; 1997 Aug; 153(2):333-9. PubMed ID: 9271860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C; Dubreuil L; Sedallian A; Romond C
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.
    Hurlbut S; Cuchural GJ; Tally FP
    Antimicrob Agents Chemother; 1990 Jan; 34(1):117-20. PubMed ID: 2327745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
    Malouin F; Lamothe F
    Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactamases from Bacteroides fragilis active against oximino-cephalosporins.
    Werner RG; Appel KR; Erne AM
    Arzneimittelforschung; 1985; 35(1A):348-50. PubMed ID: 3872669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of a new beta-lactamase from Pseudomonas cepacia.
    Hirai K; Iyobe S; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Mar; 17(3):355-8. PubMed ID: 6968539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on beta-lactamase in Bacteroides fragilis.
    Nord CE; Dornbusch K; Olsson B
    Infection; 1980; 8 Suppl 2():S167-70. PubMed ID: 6969692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.